Tissue Diagnostics: Technologies and Global Markets

Tissue Diagnostics: Technologies and Global Markets

  • BCC Research
  • September 2021
  • Medical Equipments
  • 262 pages

Report Description

Summay:

The three major types of tissue diagnostics tests include - 

  • Hematoxylin and eosin (H&E) is the most widely used stain in medical diagnosis, comprising about 80% of tissues used for in vitro diagnostics, and is key for highlighting structures in tissue for evaluation. In fact, virtually all patients suspected of having cancer have H&E and about 80% of cancers are diagnosed from the H&E alone.
  • Immunohistochemistry (IHC) is the process of using antibodies to stain proteins, which greatly increases the ability to identify categories of cells.
  • In situ hybridization (ISH) is an advanced technique to identify specific DNA or RNA molecules.

The most significant market trend during 2020 was the origin and global spread of COVID-19, the disease caused by the novel coronavirus. Originating in late 2019 in China, the virus quickly became a global pandemic. Global health organizations and diagnostic manufacturers quickly developed and approved tests for the virus. This effort overwhelmed all other trends in 2020. One effect of this activity was a complete halt of merger and acquisition activity among major diagnostic manufacturers in 2020. The global market for tissue diagnostic test productswas estimated to be REDACTED in 2020 and expected to grow at a compound annual growth rate (CAGR) of REDACTED to reach REDACTED through 2026. North America and Europe accounted for REDACTED of the total market for tissue diagnostics in 2020. Asia-Pacific occupied REDACTED of the global market, while the Rest of the World region accounted for REDACTED in 2020. North America is expected to grow at a moderate CAGR of REDACTED through 2026, while Europe should grow at a CAGR of REDACTED. While the Rest of the World region’s CAGR is at REDACTED, Asia-Pacific is the fastest-growing region with a double-digit growth rate of REDACTED.

Because of its large population and its position as a medical technology innovation hub, North America is the global leader in terms of tissue diagnostics utilization. It remains the largest market, accounting for roughly 42.0% of the total market in 2020. The emerging markets of India, China, Russia and Brazil are poised to grow at double-digit growth rates due to rising incomes, growing healthcare budgets and heightened health awareness among the population.

In Asia-Pacific, there is increasing demand for tissue diagnostic test devices, as more people are concerned about quality healthcare. Further, the expanding aging population is leading to a significant rise in the volume of clinical tests performed in laboratories. The Asia-Pacific region is currently dominated by Japan, with the largest share of revenues growing at a stable growth rate. In the coming years, however, the Asia-Pacific market is expected to be driven by the emerging economies, such as China, followed by India.

Report Scope:

The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, South Korea, Taiwan, Africa, Australia, Brazil, and Russia, among others. The report also examines market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the industry through their best practices in the research and development of tissue diagnostic tests. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.

This study will provide information on these areas - 

  • Structure and current market size of the market for tissue diagnostics as outlined with forecasts through 2026.
  • Impact of chronic diseases, growing and aging populations.
  • Current technology and product suppliers and key innovations.
  • A look at the trends affecting the market.
  • Markets by each segment of type of test (general culture test, AST/ID tests and blood culture tests).
  • A global overview showing market data for North America, Europe, Asia-Pacific and Rest of the World.
  • Emerging opportunities and potential investment opportunity areas for tissue diagnostics.
  • Profiles for more than 20 companies in the industry with significant contributions and market shares.

Report Includes:

  • 107 data tables and 28 additional tables
  • An overview of the global market for tissue diagnostic testing
  • Estimation of the market size and analyses of the global market trends, with data from 2018 to 2020, estimates for 2021 with projection of CAGR through 2026
  • Market share analysis of tissue diagnostic testing based on type, application, end user and geography
  • Detailed description of the three major tissue diagnostics tests, i.e., hematoxylin and eosin (H&E), immunohistochemistry (IHC) and in situ hybridization (ISH)
  • Description of molecular diagnostic tests including antigen tests, antibody (serology) tests and in vitro diagnostic testing, and information on alternative options for diagnostic tests
  • Details about COVID-19 global pandemic, its testing basics and specific tests for the management of COVID-19 patients
  • Identification of new opportunities, challenges and technological changes within the industry
  • Assessment of regulatory structure, pricing and reimbursement scenario, pipeline analysis and FDA product approvals in 2020
  • Company profiles of major players in the market, including Abbott Diagnostics Inc., Becton, Dickinson and Co., General Electric, Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific Inc.

Countries Covered

  • Global

Keywords

  • Tissue Diagnostic Testing Market

Have query on this report?

Make an Enquiry

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Readership
Scope of Report
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights
Introduction

Chapter 3 Market Landscape
COVID-19 Global Pandemic
Coronavirus Disease 2019 Testing Basics
Diagnostic Tests with Alternative Options
Molecular Diagnostic Tests
Increasing Access to Testing
Antigen Tests
Antibody (Serology) Tests
In Vitro Diagnostic Testing EUAs
Diagnostic Tests
Serology/Antibody Tests
Tests for the Management of COVID-19 Patients
Market Overview and Segmentation
Key Findings
Factors Influencing the Global Market for Tissue Diagnostics
Drivers
Challenges
Regulatory Landscape
IVD Regulations in North America
IVD Regulations in Europe
IVD Regulations in Asia-Pacific
IVD Regulations in Rest of the World

Chapter 4 Global Market for Tissue Diagnostics by Type of Test
Tissue Diagnostics
Trends in the Tissue Diagnostic Test Segments
Blood Culture
General Cultures (Urine/Saliva/Stool/Sputum/CSF and Other Body Fluids)
Identification and Antibiotic Susceptibility Testing (ID/AST)
FDA Product Approvals in 2020

Chapter 5 Global Market for Tissue Diagnostics by Application
Oncology
Tissue Typing
Pathogen Detection

Chapter 6 Global Market for Tissue Diagnostics by Region
Introduction
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Western Europe
Russia
Poland
Turkey
Greece
Czech Republic
Rest of Central and Eastern Europe
Asia-Pacific
Key Growth Drivers
China
India
Japan
South Korea
Australia
Taiwan
Rest of Asia-Pacific
Rest of the World

Chapter 7 Global Market for Tissue Diagnostics by End User/End Use
End Users/End Uses
Professional Laboratories
Emergency Care/Bed Side/OTC/Self-testing

Chapter 8 Competitive Landscape
Market Share Analysis
Mergers and Acquisitions
Product Approvals

Chapter 9 Company Profiles
ABBOTT DIAGNOSTICS INC.
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER (PART OF DANAHER)
BECTON DICKINSON AND CO.
BIOMERIEUX
Bio-Rad
GENERAL ELECTRIC
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
MERCK KGAA
ORTHO CLINICAL DIAGNOSTICS
QIAGEN N.V.
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC

Chapter 10 Appendix: Market Participants and List of Acronyms
Market Participants in Tissue Diagnostics
List of Acronyms

List of Tables

Summary Table A : Global Market for Tissue Diagnostics, by Region, Through 2026
Summary Table B : Global Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 1 : Total COVID-19 Cases and Deaths, by WHO Region/Country, August 9, 2021
Table 2 : Different Types of Coronavirus Tests, 2020
Table 3 : Individual EUAs for Molecular Diagnostic Tests for SARS-CoV-2, Feb. 1, 2021
Table 4 : Authorized Molecular-Based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2, Feb. 1, 2021
Table 5 : Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2, Feb. 1, 2021
Table 6 : Individual EUAs for Serology Tests for SARS-CoV-2, Feb. 1, 2021
Table 7 : Individual EUAs for IVDs for the Management of COVID-19 Patients, Feb. 1, 2021
Table 8 : Types of Diagnostic Tests and How They are Regulated
Table 9 : Changes in IVD Regulations in Asia-Pacific, 2020
Table 10 : Global Market for Tissue Diagnostics for Blood Culture, by Region, Through 2026
Table 11 : Global Market for Tissue Diagnostics for General Cultures, by Region, Through 2026
Table 12 : Global Market for Tissue Diagnostics for ID/AST, by Region, Through 2026
Table 13 : FDA Bacteriology Products Approved in 2020
Table 14 : FDA Virology Products Approved in 2020
Table 15 : Global Market for Tissue Diagnostics, by Application, Through 2026
Table 16 : Global Market for Tissue Diagnostics in Oncology, by Region, Through 2026
Table 17 : Global Market for Tissue Diagnostics for Tissue Typing, by Region, Through 2026
Table 18 : Global Market for Tissue Diagnostics for Pathogen Detection, by Region, Through 2026
Table 19 : Global Market for Tissue Diagnostics, by Region, Through 2026
Table 20 : North American Market for Tissue Diagnostics, by Country, Through 2026
Table 21 : North American Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 22 : North American Market for Tissue Diagnostics, by Application, Through 2026
Table 23 : North American Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 24 : U.S. Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 25 : U.S. Market for Tissue Diagnostics, by Application, Through 2026
Table 26 : U.S. Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 27 : Canadian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 28 : Canadian Market for Tissue Diagnostics, by Application, Through 2026
Table 29 : Canadian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 30 : Mexican Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 31 : Mexican Market for Tissue Diagnostics, by Application, Through 2026
Table 32 : Mexican Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 33 : European Market for Tissue Diagnostics, by Country, Through 2026
Table 34 : European Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 35 : European Market for Tissue Diagnostics, by Application, Through 2026
Table 36 : European Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 37 : Rising Geriatric Population in Germany, 2000-2030
Table 38 : Healthcare Expenditures in Germany, 2016-2020
Table 39 : German Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 40 : German Market for Tissue Diagnostics, by Application, Through 2026
Table 41 : German Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 42 : U.K. Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 43 : U.K. Market for Tissue Diagnostics, by Application, Through 2026
Table 44 : U.K. Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 45 : Healthcare Spending and Financing in France, 2005-2020
Table 46 : French Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 47 : French Market for Tissue Diagnostics, by Application, Through 2026
Table 48 : French Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 49 : Spanish Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 50 : Spanish Market for Tissue Diagnostics, by Application, Through 2026
Table 51 : Spanish Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 52 : Italian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 53 : Italian Market for Tissue Diagnostics, by Application, Through 2026
Table 54 : Italian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 55 : Rest of Western European Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 56 : Rest of Western European Market for Tissue Diagnostics, by Application, Through 2026
Table 57 : Rest of Western European Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 58 : Russian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 59 : Russian Market for Tissue Diagnostics, by Application, Through 2026
Table 60 : Russian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 61 : Polish Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 62 : Polish Market for Tissue Diagnostics, by Application, Through 2026
Table 63 : Polish Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 64 : Turkish Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 65 : Turkish Market for Tissue Diagnostics, by Application, Through 2026
Table 66 : Turkish Market for Tissue Diagnostics, by End User/End Use/End Use, Through 2026
Table 67 : Greek Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 68 : Greek Market for Tissue Diagnostics, by Application, Through 2026
Table 69 : Greek Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 70 : Czech Republic Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 71 : Czech Republic Market for Tissue Diagnostics, by Application, Through 2026
Table 72 : Czech Republic Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 73 : Rest of Central and Eastern European Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 74 : Rest of Central and Eastern European Market for Tissue Diagnostics, by Application, Through 2026
Table 75 : Rest of Central and Eastern European Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 76 : Asia-Pacific Market for Tissue Diagnostics, by Country, Through 2026
Table 77 : Asia-Pacific Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 78 : Asia-Pacific Market for Tissue Diagnostics, by Application, Through 2026
Table 79 : Asia-Pacific Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 80 : Chinese Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 81 : Chinese Market for Tissue Diagnostics, by Application, Through 2026
Table 82 : Chinese Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 83 : Indian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 84 : Indian Market for Tissue Diagnostics, by Application, Through 2026
Table 85 : Indian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 86 : Forecast Japanese Trends in Aging Population, 2010-2040
Table 87 : Japanese Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 88 : Japanese Market for Tissue Diagnostics, by Application, Through 2026
Table 89 : Japanese Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 90 : South Korean Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 91 : South Korean Market for Tissue Diagnostics, by Application, Through 2026
Table 92 : South Korean Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 93 : Australian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 94 : Australian Market for Tissue Diagnostics, by Application, Through 2026
Table 95 : Australian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 96 : Taiwanese Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 97 : Taiwanese Market for Tissue Diagnostics, by Application, Through 2026
Table 98 : Taiwanese Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 99 : Rest of Asia-Pacific Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 100 : Rest of Asia-Pacific Market for Tissue Diagnostics, by Application, Through 2026
Table 101 : Rest of Asia-Pacific Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 102 : Rest of the World Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 103 : Rest of the World Market for Tissue Diagnostics, by Application, Through 2026
Table 104 : Rest of the World Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 105 : Global Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 106 : Global Market for Tissue Diagnostics for Professional Laboratories, by Region, Through 2026
Table 107 : Global Market for Tissue Diagnostics for Emergency Care/Bed Side/OTC/ Self-testing, by Region, Through 2026
Table 108 : Global Company Market Shares of Tissue Diagnostics, 2020
Table 109 : Diagnostic Manufacturer Mergers and Acquisitions, 2016-2021
Table 110 : U.S. FDA Approvals of High-Complexity IVD Products, 2019-2020
Table 111 : Abbott Laboratories: Key Developments, 2021
Table 112 : Beckman Coulter: Key Developments, 2021
Table 113 : BD: Key Developments, 2021
Table 114 : bioMeriux: Key Developments, 2021
Table 115 : Bio-Rad: Key Developments, 2021
Table 116 : General Electric: Financials, 2019
Table 117 : GE Healthcare: Product Portfolio
Table 118 : GE Healthcare: Recent Developments, 2021
Table 119 : F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 120 : F. Hoffmann-La Roche Ltd.: Revenues, by Segment, 2016-2018
Table 121 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
Table 122 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 123 : F. Hoffmann-La Roche Ltd.: Recent Developments, 2021
Table 124 : Hologic: Product Portfolio
Table 125 : Hologic: Financials, 2018-2020
Table 126 : Hologic: Key Developments, 2021
Table 127 : Siemens Healthineers AG: Key Products
Table 128 : Siemens Healthineers AG: Product Segments
Table 129 : Siemens Healthineers AG: Financials, 2019
Table 130 : Siemens Healthineers AG: Key Developments, 2021
Table 131 : Thermo Fisher Scientific Inc.: Financials, 2018 and 2019
Table 132 : Thermo Fisher Scientific Inc.: Products and Services
Table 133 : Thermo Fisher Scientific Inc.: Key Developments, 2021

Success Stories

Our Clients